SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
292.60    7.20 (2.52%)
Bid:
292.20
Ask:
292.80
Spread: 0.60 (0.205%)
Market Cap: £1.01b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

7 Apr 2015 16:28

RNS Number : 5353J
Breedon Aggregates Ld
07 April 2015
 



 

 

7 April 2015

 

BREEDON AGGREGATES LIMITED

(the "Company")

 

Directors' Dealings

 

The Company announces that on 2 April 2015 the following directors of the Company (the "Executive Directors") were granted awards under the Company's Performance Share Plans ("PSPs") to acquire the number of ordinary shares of nil par value in the Company ("Ordinary Shares") set against their names below. The awards are expected to vest on 2 April 2018, subject to the satisfaction of a performance condition based on underlying EPS growth being significantly in excess of growth in RPI over the three year period ending on 31 December 2017.

 

Director

Ordinary Shares granted

Peter Tom CBE*

701,098

Simon Vivian

967,033

Rob Wood

527,472

 

*The Award to Peter Tom CBE was granted to Rise Rocks Limited, a company in which Mr Tom has a beneficial interest, which provides the services of Mr Tom as Chairman to the Company and was structured as an option at an option price equal to 1 pence per Ordinary Share . Once vested the option may be exercised at any time up to the 4th anniversary of the date of grant. The awards to Simon Vivian and Rob Wood were structured as conditional awards.

 

As at the date of this announcement the Executive Directors also have the following further interests in Ordinary Shares arising from previous awards made under the PSPs:

Director

Ordinary Shares

Peter Tom CBE

701,098

Simon Vivian

967,033

Rob Wood

483,516

 

In addition, the Executive Directors also have interests in the following Ordinary Shares:

 

Director

Ordinary Shares

Percentage of Issued Share Capital

Peter Tom CBE

48,291,867

4.52%

Simon Vivian

16,509,371

1.54%

Rob Wood

100,000

0.01%

 

 

For further information:

 

Breedon Aggregates Limited

Simon Vivian, Group Chief Executive 01332 694010

Rob Wood, Group Finance Director

 

Stephen Jacobs, Head of Communications 07831 764592

 

Cenkos Securities plc (Nomad)

Max Hartley 020 7397 8900

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFESRIDIIE
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.